Oppenheimer Raises Lam Research Price Target to $265
Oppenheimer analyst Ed Yang raised the price target on Lam Research (NASDAQ: LRCX) to $265.00 (from $200.00) while maintaining an Outperform rating.
“Lam’s implicitly guiding to ~24%+ CY26 revenue growth (WFE +23% plus >1% share gain), well above our prior ~19%E.
Management also noted that this robust outlook’s constrained by cleanroom availability, implying pent-up demand extending growth into CY27.
Given strength, Lam plans to refresh its multi-year targets (CY28E $26B revenue, $6.50 EPS), with the possibility revenue’s achieved two years ahead of plan this year.
Notably, Lam rarely provides annual guidance, let alone multi-year directional commentary, underscoring unusual confidence in accelerating momentum.
We raise FY26E revenue/EPS by 4%/7%, FY27E by 7%/11%, and lift our price target to $265 (from $200), extending recent elevated ~40x FY27E P/E.
LRCX remains our top pick and best-positioned semicap to serve AI-driven demand, although the group’s euphoric sentiments gives us pause.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
